Search

Search bills, members, committees and pages...

FULCRUM THERAPEUTICS

7 federal lobbying filings, 2025 to 2026.

FULCRUM THERAPEUTICS is a client on 7 federal lobbying filings, 2025 to 2026, reporting $270K across them. Rare disease biopharma company Based in Massachusetts.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
THE MCMANUS GROUP7$270K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$110K
20255$160K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues7

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1796Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act…6
S. 735Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act…6
H.R. 1262Mikaela Naylon Give Kids a Chance Act2
S. 932Give Kids a Chance Act of 20252

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
FULCRUM THERAPEUTICSTHE MCMANUS GROUP2026 second_quarter$60KJul 20, 2026
FULCRUM THERAPEUTICSTHE MCMANUS GROUP2026 first_quarter$50KApr 20, 2026
FULCRUM THERAPEUTICSTHE MCMANUS GROUP2025 fourth_quarter$40KJan 20, 2026
FULCRUM THERAPEUTICSTHE MCMANUS GROUP2025 third_quarter$40KOct 20, 2025
FULCRUM THERAPEUTICSTHE MCMANUS GROUP2025 second_quarter$40KJul 21, 2025
FULCRUM THERAPEUTICSTHE MCMANUS GROUP2025 first_quarter$40KMay 6, 2025
FULCRUM THERAPEUTICSTHE MCMANUS GROUP2025 first_quarterJan 17, 2025